PTPRS and hepatocellular carcinoma: Both PI3K inhibitor and MEK1/2 inhibitor effectively inhibited the cell migration and invasion induced by enhanced EGFR phosphorylation, indicating EGFR/PI3K/MEK signaling was downstream of PTPRS in HCC.